Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Evaluation of pazopanib cytotoxicity to normal vascular endothelial cells in vitro: A comment on Goto et al.

Kitamura S, Yanagi T, Maeda T, Imafuku K, Hata H, Masuzawa M, Shimizu H.

J Dermatol. 2019 Mar 25. doi: 10.1111/1346-8138.14860. [Epub ahead of print] No abstract available.

PMID:
30908708
2.

The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melanoma.

Maeda T, Yoshino K, Nagai K, Oaku S, Kato M, Hiura A, Hata H.

Acta Oncol. 2019 Mar;58(3):379-381. doi: 10.1080/0284186X.2018.1541252. Epub 2019 Jan 7. No abstract available.

PMID:
30614355
3.

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Wada N, Irie H, Hidaka T, Hashimoto A, Aiba S.

Front Oncol. 2018 Nov 19;8:530. doi: 10.3389/fonc.2018.00530. eCollection 2018.

4.

Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients.

Maeda T, Yoshino K, Nagai K, Oaku S, Kato M, Hiura A, Hata H.

Br J Dermatol. 2018 Nov 17. doi: 10.1111/bjd.17434. [Epub ahead of print] No abstract available.

PMID:
30447078
5.

Reply to "Early ambulation versus bedrest after skin grafting in extramammary Paget's disease".

Maeda T, Yoshino K, Nagai K, Oaku S, Kato M, Hiura A, Hata H.

J Dermatol. 2018 Nov 16. doi: 10.1111/1346-8138.14707. [Epub ahead of print] No abstract available.

PMID:
30447024
6.

Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S.

Cancer Res. 2018 Dec 15;78(24):6795-6806. doi: 10.1158/0008-5472.CAN-18-1495. Epub 2018 Nov 2.

PMID:
30389700
7.

Successful outcome of early ambulation after extensive skin grafting in extramammary Paget's disease.

Maeda T, Yoshino K, Nagai K, Oaku S, Kato M, Hata H.

J Dermatol. 2018 Dec;45(12):1456-1458. doi: 10.1111/1346-8138.14645. Epub 2018 Sep 14.

PMID:
30216499
8.

Horn-like tumour on the dorsal hand.

Kosumi H, Yanagi T, Maeda T, Sugai T, Imafuku K, Hata H, Shimizu H.

Lancet Infect Dis. 2018 Jun;18(6):696. doi: 10.1016/S1473-3099(18)30098-7. No abstract available.

PMID:
29856358
9.

Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.

Hirai I, Tanese K, Nakamura Y, Otsuka A, Fujisawa Y, Yamamoto Y, Hata H, Fujimura T, Matsushita S, Yoshino K, Kameyama K, Amagai M, Funakoshi T.

Med Oncol. 2018 May 9;35(6):92. doi: 10.1007/s12032-018-1154-z.

PMID:
29744813
10.

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S.

Oncotarget. 2018 Feb 15;9(21):15542-15551. doi: 10.18632/oncotarget.24509. eCollection 2018 Mar 20.

11.

Bullous pemphigoid with the deposition of IgG2 but not IgG1, IgG3 nor IgG4 autoantibodies at the basement membrane zone.

Yoshimoto N, Ujiie H, Zheng M, Iwata H, Kosumi H, Hata H, Shimizu H.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e344-e346. doi: 10.1111/jdv.14920. Epub 2018 Mar 26. No abstract available.

PMID:
29512195
12.

Dermoscopic evaluation for skin grafts after surgery; neo-vascularization correlates with survival of skin grafts: A prospective study.

Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Fujioka Y, Ohba Y, Shimizu H.

J Dermatol Sci. 2018 May;90(2):213-216. doi: 10.1016/j.jdermsci.2018.01.014. Epub 2018 Feb 2. No abstract available.

PMID:
29428816
13.

Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S.

Br J Dermatol. 2018 Jul;179(1):213-215. doi: 10.1111/bjd.16427. Epub 2018 Apr 24. No abstract available.

PMID:
29405254
14.

Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.

Kitamura S, Yanagi T, Inamura-Takashima Y, Imafuku K, Hata H, Uehara J, Ishida Y, Otsuka A, Hirata K, Shimizu H.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e285-e287. doi: 10.1111/jdv.14821. Epub 2018 Feb 20. No abstract available.

PMID:
29377285
15.

Dermoscopic features of Bednar tumor: Report of a case.

Maeda T, Watabe Y, Yanagi T, Imafuku K, Kitamura S, Hata H, Nomura T, Shimizu H.

J Dermatol. 2018 Jul;45(7):e179-e180. doi: 10.1111/1346-8138.14232. Epub 2018 Jan 16. No abstract available.

PMID:
29341231
16.

Apocrine mixed tumour on the abdomen: an atypical location.

Mai S, Fujita Y, Sugai T, Imafuku K, Hata H, Shinkuma S, Nomura T, Kawagishi N, Shimizu H.

Eur J Dermatol. 2018 Apr 1;28(2):234-235. doi: 10.1684/ejd.2017.3200. No abstract available.

PMID:
29336312
17.

Case of successfully switching from nivolumab to vemurafenib with oral corticosteroids.

Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H.

J Dermatol. 2018 Jun;45(6):e156. doi: 10.1111/1346-8138.14199. Epub 2018 Jan 6. No abstract available.

PMID:
29315740
18.

Cutaneous inflammatory myofibroblastic tumour: a case report and literature review.

Nakazato S, Yanagi T, Inamura Y, Kitamura S, Hata H, Shimizu H.

Eur J Dermatol. 2017 Dec 1;27(6):676-677. doi: 10.1684/ejd.2017.3213. Review. No abstract available.

PMID:
29311045
19.

Successful treatment of hidradenitis suppurativa with rituximab for a patient with idiopathic carpotarsal osteolysis and chronic active antibody-mediated rejection.

Takahashi K, Yanagi T, Kitamura S, Hata H, Imafuku K, Iwami D, Hotta K, Morita K, Shinohara N, Shimizu H.

J Dermatol. 2018 May;45(5):e116-e117. doi: 10.1111/1346-8138.14144. Epub 2017 Nov 23. No abstract available.

PMID:
29168221
20.

A severe case of mango dermatitis.

Miyazawa H, Nishie W, Hata H, Matsumura K, Shimizu H.

J Eur Acad Dermatol Venereol. 2018 Apr;32(4):e160-e161. doi: 10.1111/jdv.14656. Epub 2017 Nov 22. No abstract available.

PMID:
29080314

Supplemental Content

Loading ...
Support Center